Rituxan (rituximab) - Hepatitis B Virus (hbv) Recurrence In Patients: Updates On Screening And Management - For Health Professionals

RITUXAN (rituximab) Recall Summary Rituxan, a medication used to treat certain cancers and immune conditions, can cause hepatitis B virus to reactivate in patients who carry the virus but don't have active infection. Health professionals in Canada are being notified about updated screening and management procedures to identify and handle cases of HBV reactivation in patients taking this drug. This recall affects Rituxan distributed across Canada.

Reason

Product safety

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2013-07-29

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/7ca9c45e-8e52-4034-a1fe-4a7e67206941